Search results
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 6 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
Why Do I Have a Rash Between My Breasts?
Verywell Health via Yahoo News· 3 days agoA rash between the breasts can develop for a variety of reasons, including heat, infection, or other more serious conditions like cancer. Here’s what to...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 4 days agoZai Lab has dosed the first subject in a Phase II clinical trial of ZL-1102, an investigational...
Thick Toenails
Health via Yahoo News· 2 days agoTreatments Thick toenails are often chronic and can be difficult to treat. There’s no quick fix, and unfortunately, it can take more than a year for...
What Can Nail Changes Say About Our Health? Here's What To Know
IFLScience· 3 days agoClues about your health may be right at your fingertips.
Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV)
Insider Monkey via Yahoo Finance· 38 minutes agoWe recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article...
Palisade's ulcerative colitis drug prevents symptoms in mice, is nontoxic in dogs
FierceBiotech· 5 days agoPalisade Bio’s PDE4 inhibitor to treat the inflammatory bowel disease ulcerative colitis appears to...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 6 days agoTremfya is an interleukin (IL)-23 and CD64-inhibiting monoclonal antibody. It was first approved as...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 7 hours agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 4 days agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...